Copyright
©The Author(s) 2017.
World J Transplant. Oct 24, 2017; 7(5): 250-259
Published online Oct 24, 2017. doi: 10.5500/wjt.v7.i5.250
Published online Oct 24, 2017. doi: 10.5500/wjt.v7.i5.250
Figure 1 Correlation of harvested CD34+ cells counts with white blood cell count and peripheral blood CD34+ cell count.
A: Correlation of harvested CD34+ cells counts with white blood cell count; B: Correlation of harvested CD34+ cells counts with peripheral blood CD34+ cell count. Reprinted by permission from Macmillan Publishers Ltd: Bone Marrow Transplant 1997[16]. http://www.nature.com/bmt/index.html.
Figure 2 Bone marrow microenvironment (A) at physiologic state and effects of (B) granulocyte colony stimulating factor mobilization and (C) Plerixafor mobilization.
Reprinted from Journal of Cellular Biochemistry, Vol 99/edition 3, Bruno Nervi, Dan C. Link, John F DiPersio, Cytokines and Hematopoietic Stem Cell Mobilization, 690-705, 2010, with permission from Wiley[26]. G-CSF: Granulocyte colony stimulating factor; HSC: Hematopoietic stem cell; SDF-1: Stromal cell-derived factor-1; VCAM-1: Vascular cell adhesion molecule.
Figure 3 Mobilization strategies at authors’ institution.
CM: Chemomobilization; G-CSF: Granulocyte colony stimulating factor.
- Citation: Wallis WD, Qazilbash MH. Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy? World J Transplant 2017; 7(5): 250-259
- URL: https://www.wjgnet.com/2220-3230/full/v7/i5/250.htm
- DOI: https://dx.doi.org/10.5500/wjt.v7.i5.250